Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q1 EPS of ($0.59), $0.24 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral